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The Cdc6 protein is an essential component of pre-replication complexes (preRCs), which assemble at origins of DNA
replication during the G1 phase of the cell cycle. Previous studies have demonstrated that, in response to ionizing
radiation, Cdc6 is ubiquitinated by the anaphase promoting complex (APCCdh1) in a p53-dependent manner. We find,
however, that DNA damage caused by UV irradiation or DNA alkylation by methyl methane sulfonate (MMS) induces
Cdc6 degradation independently of p53. We further demonstrate that Cdc6 degradation after these forms of DNA damage
is also independent of cell cycle phase, Cdc6 phosphorylation of the known Cdk target residues, or the Cul4/DDB1 and
APCCdh1 ubiquitin E3 ligases. Instead Cdc6 directly binds a HECT-family ubiquitin E3 ligase, Huwe1 (also known as
Mule, UreB1, ARF-BP1, Lasu1, and HectH9), and Huwe1 polyubiquitinates Cdc6 in vitro. Degradation of Cdc6 in
UV-irradiated cells or in cells treated with MMS requires Huwe1 and is associated with release of Cdc6 from chromatin.
Furthermore, yeast cells lacking the Huwe1 ortholog, Tom1, have a similar defect in Cdc6 degradation. Together, these
findings demonstrate an important and conserved role for Huwe1 in regulating Cdc6 abundance after DNA damage.
INTRODUCTION
Duplication of large mammalian genomes requires that
DNA replication initiate at thousands of chromosomal ori-
gins. In order for an origin to be competent for replication, it
must first be bound by a multiprotein complex, the prerep-
lication complex (preRC). PreRCs are constructed in a step-
wise process through the chromatin binding of the origin
recognition complex (ORC), which then recruits both the
Cdc6 ATPase and Cdt1, two proteins that are required for
the stable loading of the minichromosome maintenance com-
plex (MCM). The Cdc6 and Cdt1-dependent loading of MCM
complexes at origins licenses them for replication during the
G1 phase of the cell cycle. Sufficient preRCs must be assembled
during G1 to promote complete replication, but new preRCs
must not assemble after S phase begins because relicensing of
previously fired origins leads to rereplication and genome
instability (Vaziri et al., 2003; Melixetian et al., 2004; Zhu et al.,
2004; Archambault et al., 2005). For these reasons, preRC as-
sembly is one of the most highly regulated events in the control
of DNA replication. Cells restrict preRC assembly to the G1
period through a combination of overlapping mechanisms that
regulate individual preRC components (reviewed in Bell and
Dutta, 2002; Blow and Hodgson, 2002; Nishitani and Lygerou,
2002; Diffley, 2004; Machida et al., 2005; Fujita, 2006).
Cdc6 is not only an essential factor for preRC construc-
tion, but it has also been implicated in the activation of the
cell cycle checkpoint that prevents entry into mitosis while
DNA replication is incomplete (Clay-Farrace et al., 2003;
Oehlmann et al., 2004; Lau et al., 2006). These observations
suggest that Cdc6 functions not only during G1, but also in
later cell cycle stages. Moreover, Cdc6 plays a role in setting
the threshold for commitment to apoptosis (Pelizon et al.,
2002; Feng et al., 2003; Yim et al., 2003). These findings
suggest that the regulation of Cdc6 has important conse-
quences for multiple aspects of cell cycle control and cell fate
determination. In addition, the high levels of Cdc6 protein
observed in multiple cancers may contribute to cell cycle
regulation defects and genome instability that consequently
promote tumor progression (Williams et al., 1998; Ohta et al.,
2001; Karakaidos et al., 2004; Semple and Duncker, 2004).
Cdc6 is subject to multiple forms of regulation, including
both transcriptional and posttranscriptional mechanisms.
The human cdc6 gene is regulated by the Rb-E2F transcrip-
tional program that results in peak cdc6 mRNA levels in late
G1 phase (Hateboer et al., 1998; Ohtani et al., 1998; Yan et al.,
1998). The Cdc6 protein is degraded each cell cycle in early
G1 as a consequence of ubiquitination by the Cdh1-activated
form of the anaphase promoting complex (APC), a cell cy-
cle–regulated ubiquitin E3 ligase (Petersen et al., 2000). Ubiq-
uitination of Cdc6 by APCCdh1 is regulated not only by cell
cycle–dependent fluctuations in APC activity, but also by
phosphorylation of Cdc6 by cyclin-dependent kinases, most
notably cyclin E/Cdk2. Cdk2-mediated phosphorylation
blocks the association of Cdc6 with the Cdh1 protein, thus
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stabilizing Cdc6 when Cdk2 is active (Duursma and Agami,
2005; Mailand and Diffley, 2005).
Cdc6 is also ubiquitinated and degraded in response to
DNA damage (Blanchard et al., 2002; Duursma and Agami,
2005). Cells may eliminate Cdc6 to reduce the possibility of
rereplicating DNA or to promote checkpoint functions that
block mitosis with damaged DNA. One mechanism to ubi-
quitinate Cdc6 relies on inhibition of Cdk2 during a check-
point response as a result of p53-mediated induction of the
p21 Cdk inhibitor. Reduced Cdk2 activity destabilizes Cdc6
because it is no longer protected from ubiquitination by
APCCdh1 (Duursma and Agami, 2005). However, this path-
way does not fully account for the degradation of Cdc6 after
DNA damage. p53 is not required for Cdc6 degradation
after UV irradiation or after treatment of cells with various
DNA-alkylating agents such as adozelesin or methyl meth-
ane sulfonate (MMS; Blanchard et al., 2002). Importantly,
APC activity itself is inhibited during S phase and G2, times
when it may be particularly important to regulate Cdc6 in
order to prevent rereplication or to promote checkpoint
activation. These observations implicate an as yet unidenti-
fied APC-independent pathway for degradation of Cdc6.
We sought to determine this p53- and APC-independent
mechanism of Cdc6 degradation, and we report here our
finding that Cdc6 stability after DNA damage is controlled
by a novel ubiquitin ligase, Huwe1.
MATERIALS AND METHODS
Cells and Treatments
HeLa, NHF1-hTERT (Heffernan et al., 2002), and U-2OS cells were cultured in
DMEM (Invitrogen, Carlsbad, CA) with 10% fetal calf serum (Sigma, St.
Louis, MO). MMS, MG132 (Z-Leu-Leu-Leu-H), nocodazole, and cyclohexi-
mide (CHX) were purchased from Sigma (St. Louis, MO). UV irradiation was
performed using a germicidal UV-C (254-nm) lamp (General Electric, Cleve-
land, OH) or alternatively by treatment of phosphate-buffered saline (PBS)-
washed cells in a Stratalinker (Stratagene, La Jolla, CA). The endogenous
Cdc6 locus in both the yeast strain BY4741 and its isogenic derivative
tom1::G418 (Invitrogen) was tagged at the 3 end of the cdc6 open reading
frame with 13 tandem copies of the myc (9E10) epitope by the method of
Longtine et al. (1998) to yield strains JCY200 (wt) and JCY201 (tom1), respec-
tively. The tom1 deletion was confirmed by the temperature-sensitive growth
at 37°C (data not shown).
Small Interfering RNA
Small interfering (siRNA) targeting Huwe1 (5-GAGUUUGGAGUUUGU-
GAAGTT-3), human Cdh1 (5-UGUGAAGUCUCCCAGUCAGTT-3), and
the negative control green fluorescent protein (GFP; 5-GGCUACGUCCAG-
GAGCGCACCTT-3) were synthesized by Invitrogen and transfected at a
final concentration of 100 nM using Dharmafect Reagent 1 (Dharmacon,
Boulder, CO). DDB1, Cul4A, and Cul4B siRNA were described in Hu et al.
(2004); geminin siRNA was described in Ballabeni et al. (2004).
Antibodies and Immunoblots
Anti-Cdc6 (sc-9964), Anti-Cdc6 (d-1), anti-cyclin A (C-19), anti-c-Myc (sc-40),
anti-hemagglutinin (Y-11), anti-p53 (D01), anti-ScMcm2 (yN-19), anti-geminin
(FL-209) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA),
anti-cyclin B1 (V152) from Lab Vision (Fremont, CA), anti-Cdh1 (DH01) from
Biomeda (Foster City, CA), anti-Orc2 from BD PharMingen (San Diego, CA),
and anti-tubulin (DM1A) from Sigma. Phosphospecific antibodies to p53
phosphorylated on Ser15 and Chk2 phosphorylated on T69 were purchased
from Cell Signaling Technologies (Beverly, MA). Anti-Huwe1 (anti-Lasu1,
BL671) was purchased from Bethyl Laboratories (Montgomery, TX, for im-
munoprecipitations) or was the gift of S. Wing (McGill University) (Liu et al.,
2005; for immunoblots). Anti-Cul4 and anti-DDB1 antibodies were the gift of
Y. Xiong (University of North Carolina at Chapel Hill) (Hu et al., 2004);
anti-yeast phosphoglycerate kinase (PGK) was a gift of H. Dohlman (Univer-
sity of North Carolina at Chapel Hill). Relative Cdc6 abundance was deter-
mined by densitometric analysis of light exposures of immunoblots using the
ImageJ program (W. S. Rasband, ImageJ, National Institutes of Health, Be-
thesda, MD; http://rsb.info.nih.gov/ij/, 1997–2006). The ratio of Cdc6 signal
to tubulin signal (after background subtraction) is reported as the mean of
two or more experiments.
Two-Hybrid Screen
The Gal4 DNA-binding domain was inserted at the carboxy terminus of
human Cdc6 through a PCR strategy and expressed from the GPD promoter
in plasmid p2U (gift of D. Picard, Université de Genève). Cotransformants of
strain PJ69a (James et al., 1996) with one of two cDNA fusion libraries
(placental cDNA or thymus cDNA, Clontech, Palo Alto, CA) were selected on
medium containing 3 mM 3-amino-1,2,4 triazole (Sigma). More than 8 million
cotransformants of each library were screened; Huwe1 clones were identified
from both libraries.
Plasmids and Viruses
A fragment encoding the carboxy-terminal 388 residues of Huwe1 (Huwe1C;
GenBank Accession BC063505) was subcloned into pDONOR221 (Invitrogen),
followed by recombination into the glutathione S-transferase (GST) expres-
sion vector pDEST15 (Invitrogen). Adenovirus directing production of myc-
epitope tagged Cdc6 has been described (Cook et al., 2002). Cdc6S3D was
constructed by site-directed mutagenesis of serines 54, 74, and 104 to aspartic
acid in a construct that also bears a strong N-terminal nuclear localization
signal (NLS) from SV40 T antigen. A Cdc6S3D mutant adenoviral construct
without the NLS the mutation expresses a constitutively cytoplasmic protein
that is stable in quiescent cells (Cook, unpublished observations). Cdc6WT
bears the same NLS fusion.
In Vitro Protein-binding Assay
GST-Huwe1C was produced in BL21(DE3) purified on glutathione-Sepharose
(GE Healthcare, Waukesha, WI) and incubated with cell lysates prepared in
buffer 1 (50 mM HEPES, pH 7.2, 33 mM potassium acetate, 0.5 mM EDTA, 0.5
mM EGTA, 0.1% Nonidet P-40, 10% glycerol, and protease and phosphatase
inhibitors) essentially as described in Cook et al. (2004). GST-hCdc6 was
produced by infection of SF21 insect cells with GST-hCdc6 baculovirus and
purification of GST-hCdc6 was performed as described in Herbig et al. (1999).
Coimmunoprecipitation
HeLa cell nuclei were prepared by hypotonic lysis followed by brief sonica-
tion in S7 nuclease-containing buffer 1 supplemented with 1 mM CaCl2. To
aid Cdc6 solubility, NaCl was added to 250 mM for 5 min and then diluted to
45 mM. Portions of clarified lysate were reserved on ice, and the remainder
was mixed with 3 g of anti-Huwe1 (BL671) or normal rabbit serum at 4°C for
1 h. Lysates were centrifuged for 5 min at 13,000  g, and supernatants were
incubated with Protein A agarose (Roche, Indianapolis, IN) for an additional
hour. Immune complexes were washed twice with buffer 1. Bound proteins
were solubilized in 2 Huwe1 sample buffer (50 mM Tris, pH 6.8, 8 M urea,
75 mM dithiothreitol, 3% SDS, 0.05% Bromophenol blue) heated at 37°C for 5
min, and resolved by SDS-PAGE.
In Vitro Ubiquitination Assay
In a 10-l reaction, 100 ng of purified recombinant GST-Cdc6 was incubated
with an ATP-regenerating system (50 mM Tris, pH 7.6, 5 mM MgCl2, 5 mM
ATP, 10 mM creatine phosphate, 3.5 U/ml creatine kinase), 10 g ubiquitin,
10 ng human E1, 100 ng Ubch7, and Huwe1 as indicated at 37°C for 2 h in a
manner similar to that described in Zhong et al. (2005). After terminating the
reactions with SDS sample buffer, reaction products were fractionated by
SDS-PAGE (6%) and analyzed by immunoblotting with anti-Cdc6 antibody
(D-1, Santa Cruz) at 1:4000 dilution.
Chromatin fractionations were performed as described in Cook et al. (2002).
RESULTS
An APC-independent Mechanism for Cdc6 Degradation
To explore the regulation of Cdc6 after DNA damage, we
treated an asynchronous population of HeLa cells with
MMS or with UV irradiation. Similar to previous results
(Blanchard et al., 2002), both kinds of DNA damage resulted
in significant loss of endogenous Cdc6 (Figure 1A, compare
lanes 2 and 3 with lane 1), and the degradation was sensitive
to proteasome inhibition by MG132 (Figure 1A, lanes 4–6).
Under these conditions, we did not observe the caspase
cleavage product of Cdc6 after DNA damage (data not
shown); this cleavage normally occurs 12 h after induction of
apoptosis (Pelizon et al., 2002).
We next compared the kinetics of Cdc6 degradation in
HeLa cells and in normal human fibroblasts (NHF; Figure
1B) to determine if differences in Cdc6 regulation might
contribute—along with deregulated transcription—to the
high levels of Cdc6 observed in cancer cells (Williams et al.,
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1998; Ohta et al., 2001; Karakaidos et al., 2004). For this
experiment, defined numbers of actively growing, subcon-
fluent cells were analyzed for endogenous Cdc6 at various
times after UV treatment. Whole cell extracts were prepared
from 6  104 HeLas or 1.2  105 NHFs, in order to compare
the relative amounts of Cdc6 remaining at each time after
UV treatment. The overall rate of Cdc6 loss was similar in
both cell lines (Figure 1B). However, HeLa cells consistently
harbor at least 10-fold higher levels of Cdc6 per cell than
NHFs (Figure 1B, compare lanes 1 and 7). Because of these
high initial levels, even 3 h after DNA damage HeLa cells
still contained at least as much Cdc6 as the untreated normal
cells (Figure 1B, compare lanes 6 and 7). The amount of Cdc6
in naive normal cells is clearly enough to support a complete
round of genomic DNA replication; thus cancer cells with
high levels of Cdc6 have a relatively long period of abun-
dant Cdc6 after DNA damage.
We specifically tested if Cdc6 overproduction could sup-
press DNA damage–induced Cdc6 degradation by over-
whelming the capacity of the cells to target the excess pro-
tein. We infected U-2OS cells with either control adenovirus
or virus-producing Cdc6 at either moderate doses or high
doses and then treated cells with MMS to induce Cdc6
degradation. Both the ectopic and endogenous Cdc6 pro-
teins were detected by immunoblot analysis. At the lower
viral dose, ectopic Cdc6 accumulated to three times that of
endogenous Cdc6 as estimated by densitometry (data not
shown), and though it was reduced by DNA damage, some
ectopic Cdc6 protein still remained (Figure 1C, lanes 3 and
4). Increasing the level of ectopic Cdc6 further to approxi-
mately six times that of endogenous Cdc6 significantly im-
paired the ability of these cells to degrade Cdc6 in the
presence of MMS, but had no effect on the DNA damage–
induced degradation of Cdt1 (Figure 1C, lanes 7 and 8).
To determine if high levels of Cdc6 can induce rereplica-
tion, we overproduced Cdc6 in cells arrested in G2. Exten-
sive rereplication is associated with an activated cell cycle
checkpoint characterized by phosphorylation of both the
p53 tumor suppressor and the Chk2 protein kinase. These
markers are strongly induced by depletion of geminin, a
negative regulator of preRC assembly that inhibits Cdt1
(Zhu et al., 2004; Figure 1D, lane 3). We infected HCT116
(p53) cells with a high dose of Cdc6-producing adenovirus
and held these cells in nocodazole for 20 h to block mitosis.
Under these conditions, Cdc6 accumulated to 12 times that
of endogenous Cdc6 (data not shown). High levels of Cdc6
Figure 1. Cdc6 degradation after DNA damage depends on its
abundance but not cell cycle phase. (A) Asynchronous HeLa cells
were treated with 1 mM methyl methanesulfonate (MMS; lanes 2
and 5), with 30 J/m2 UV light (lanes 3 and 6) and with 20 M
MG132 (lanes 4–6), or left untreated (lane 1) as indicated. Cells were
harvested 3 h after treatment, and endogenous Cdc6 and tubulin
levels were determined by immunoblotting. (B) Cells were UV
irradiated as in A, and endogenous Cdc6 and tubulin were moni-
tored in whole cell extracts of 60,000 HeLa or 120,000 NHF-hTert
cells (normal human fibroblasts immortalized with telomerase) by
immunoblotting. Both dark and light exposures of the Cdc6 signal
are shown. (C) Asynchronous U-2OS cells were transduced with
control virus or recombinant adenovirus producing Myc5-Cdc6
at a relative MOI of 3 (lanes 1– 4) or 9 (lanes 5– 8). Twenty-four
hours after infection cells were treated with 1 mM MMS for 3 h.
Endogenous and ectopic Cdc6, Cdt1, and tubulin were detected
by immunoblotting. (D) HCT116 cells were transduced with con-
trol virus or Myc5-Cdc6 producing virus at a relative MOI of 25,
then transfected with control siRNA or siRNA targeting geminin.
Twenty-four hours after transfection, cells were synchronized in
G2/M with 100 ng/ml nocodazole for 20 h. Arrested cells were
collected and analyzed by immunoblotting for phosphorylated
Chk2, phosphorylated p53, ectopic Cdc6, or endogenous geminin
and tubulin (left) and by flow cytometry for cells with greater
than 4N DNA content (see also Supplementary Figure S1). (E)
U-2OS cells were synchronized at G2/M by treatment with 2 mM
thymidine for 24 h followed 100 ng/ml nocodazole for 16 h. They
were then collected by “mitotic shake-off” (lane 1) and replated.
Cells were harvested at 3, 6, 9, 12, 15, and 18 h after release. One
duplicate of each sample was treated with 1 mM MMS for 3 h
before harvest (lanes 3, 5, 7, 9, 11, and 13).
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induced phosphorylation of both Chk2 and p53 (Figure 1D,
compare lanes 1 and 2). Moreover, Cdc6 overproduction
was sufficient to cause rereplication detectable as an increase
in the number of cells with greater than 4N DNA content
(Figure 1D and Supplementary Figure S1). Depletion of
geminin caused robust rereplication as had been reported by
others (Mihaylov et al., 2002; Li and Blow, 2004; Melixetian et
al., 2004; Zhu et al., 2004), and the combination of high levels
of Cdc6 with geminin depletion increased the number of
rereplicating cells even further (Figure 1D, numbers 3 and 4,
and Supplementary Figure S4). We thus conclude that Cdc6
de-regulation can promote rereplication, and that the deg-
radation of both Cdc6 and Cdt1 after DNA damage may be
important for maintaining genome integrity.
Because persistent Cdc6 might contribute to genome in-
stability we sought to understand the mechanism of DNA
damage-induced Cdc6 degradation. To determine if Cdc6
degradation is affected by cell cycle stage, we synchronized
U-2OS cells at G2/M by sequential treatment with thymidine
and nocodazole followed by release from the arrest; cell cycle
position was confirmed by flow cytometry (Supplementary
Figure S2). In undamaged cells endogenous Cdc6 protein was
low in G1 and accumulated throughout S phase and G2, as
expected. Strikingly, DNA damage–induced Cdc6 degradation
at every stage of the cell cycle despite the presumed inhibition
of APC after the G1/S transition (Figure 1E).
APC-mediated Cdc6 degradation is blocked when Cdc6 is
phosphorylated by Cdk2. Mutational alteration of the Cdk
target sites to aspartic acid mimics phosphorylation and
blocks interaction with APC (Duursma and Agami, 2005;
Mailand and Diffley, 2005). Thus, if Cdc6 degradation after
UV or MMS treatment occurred by promoting dephosphor-
ylation of Cdc6 and sensitizing Cdc6 to APC, then these
aspartic acid substitutions would prevent Cdc6 degradation.
To test this possibility, we constructed adenoviral vectors to
produce myc-epitope–tagged versions of both normal Cdc6
(WT) or Cdc6 in which the Cdk target sites, serines 54, 74,
and 104, were altered to aspartic acid, Cdc6S3D. Low doses of
these viruses were used to infect HeLa cells such that the
level of ectopic Cdc6 was less than endogenous Cdc6. UV
irradiation caused the degradation of not only the endoge-
nous Cdc6 (Figure 2A, lanes 1 and 2), but also the ectopically
expressed Cdc6 (Figure 2A, lanes 3 and 4). Moreover, the
S3D mutant showed equal susceptibility to UV-induced deg-
radation (Figure 2A, lanes 5 and 6), indicating that phos-
phorylation at these serine residues does not control DNA
damage-induced Cdc6 degradation.
Cdc6 ubiquitination by APC requires the targeting sub-
unit, Cdh1 (Petersen et al., 2000; Duursma and Agami, 2005).
It was possible that during a DNA damage response, Cdc6
became more APC-sensitive by some mechanism other than
dephosphorylation at the known Cdk sites. To definitively
demonstrate that Cdc6 degradation can occur indepen-
dently of APCCdh1, we eliminated Cdh1 in cells by siRNA
transfection. Effective knockdown of Cdh1 was confirmed
by immunoblot analysis and the resulting accumulation of
cyclin B (Figure 2B). Despite the depletion of Cdh1, Cdc6
degradation after MMS treatment was unaffected (Figure 2B,
compare lanes 2 and 4). APC-mediated ubiquitination of Cdc6
after ionizing radiation requires p53 (Duursma and Agami,
2005), but we observed no difference between normal human
fibroblasts and isogenic cells deficient in p53 with regard to
their ability to degrade Cdc6 after MMS treatment (Figure 2C),
consistent with earlier findings in tumor cell lines lacking func-
tional p53 (Blanchard et al., 2002). Degradation of Cdc6 oc-
curred despite the fact that naive p53-deficient cells have
higher endogenous Cdc6 levels, presumably because of the
combined effects of the p53-dependent deregulation of Cdks on
both E2F-dependent cdc6 transcription (Hateboer et al., 1998;
Ohtani et al., 1998; Yan et al., 1998) and APC-dependent Cdc6
protein stability during G1 (Duursma and Agami, 2005;
Mailand and Diffley, 2005). We thus conclude that DNA dam-
Figure 2. Cdc6 degradation after DNA dam-
age is independent of Cdk phosphorylation,
APCCdh1, p53 status, and Cul4/DDB1. (A)
HeLa cells were infected with recombinant
adenovirus producing GFP (control), myc-
tagged Cdc6 (WT), or myc-tagged Cdc6 in
which S54, S74, and S104 have been altered to
aspartic acid. Viral doses were used that result
in levels of ectopic Cdc6 that are lower than
endogenous Cdc6 (the top panel is a longer
exposure of the Cdc6 immunoblot than the
middle panel). Cells were treated for 19 h with
3 mM thymidine to arrest in S phase before
UV irradiation. Whole cell lysates were pre-
pared 3 h after UV treatment, and both endog-
enous and ectopic Cdc6 and endogenous tu-
bulin were detected by immunoblotting. (B)
Asynchronous HeLa cells were treated with
Cdh1 siRNA (lanes 3 and 4) or control siRNA
(lanes 1 and 2) for 36 h. Three hours before
harvest MMS was added to 1 mM (lanes 2 and
4). Endogenous Cdc6, Cdh1, cyclin B, and tu-
bulin were analyzed by immunoblotting. (C)
Normal human fibroblasts (immortalized with
telomerase) or an isogenic derivative express-
ing a short hairpin RNA targeting p53 were
treated with 1 mM MMS for 3 h and analyzed for endogenous Cdc6, p53, cyclin A, tubulin, and phosphorylated p53 (Ser 15) by
immunoblotting. (D) HeLa cells were simultaneously treated with Cul4A and Cul4B siRNAs or control siRNA for 48 h followed by treatment
with 1 mM MMS for 3 h. Endogenous Cul4A and Cdc6 were analyzed by immunoblotting. (E) Asynchronous HeLa cells were transfected
with control or DDB1 siRNA for 48 h and then subjected to UV irradiation as in Figure 1A. Samples were collected at 0, 15, 45 min, and 3 h
after irradiation, and endogenous Cdc6, Cdt1, and Ddb1 were analyzed by immunoblotting. (A nonspecific band is shown as a loading
control.)
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age induces Cdc6 degradation regardless of cell cycle position,
APC activity, or p53 status.
Like Cdc6, Cdt1 is ubiquitinated and degraded after DNA
damage. Ubiquitination of Cdt1 under these conditions is
dependent on the DDB1/Cul4 ubiquitin ligase (Higa et al.,
2003; Hu et al., 2004); thus it was possible that Cul4 also
ubiquitinated Cdc6 after DNA damage. However, cells
treated with siRNAs targeting both Cul4A and Cul4B
showed no difference in the degradation of Cdc6 after MMS
treatment (Figure 2D, compare lanes 1 and 2 with lanes 3
and 4). Reduction of DDB1 by a similar siRNA strategy
significantly delayed the normally rapid destruction of Cdt1
(Figure 2E, compare lanes 2 and 6), though the remaining
DDB1 was capable of eliminating Cdt1 by later time points.
(This hypomorphic phenotype is typical of DDB1-depleted
cells; J. Hu and Y. Xiong, personal communication.) Impor-
tantly, UV-irradiated cells in which DDB1 is reduced by
siRNA treatment degraded Cdc6 with the same kinetics as
control cells (Figure 2E, compare lanes 1–4 with lanes 5–8).
We thus hypothesized that an entirely different ubiquitin
ligase plays an important role in Cdc6 ubiquitination and
degradation in response to DNA damage.
Interaction of Cdc6 with Huwe1
We identified multiple isolates of a 4374 amino acid ubiq-
uitin E3 ligase in a two-hybrid screen for proteins that
interact with Cdc6 (Figure 3A). This enzyme is a member of
the HECT family and can ubiquitinate the Mcl-1 anti-apop-
totic protein, core histones, the c-myc transcription factor,
and the p53 checkpoint mediator. These reports named the
enzyme Mule (Warr et al., 2005; Zhong et al., 2005), Lasu1
(Liu et al., 2005), HectH9 (Adhikary et al., 2005), and ARF-
BP1 (Chen et al., 2005), respectively. We use the official gene
name, HUWE1 for “HECT, UBA and WWE domain contain-
ing 1” (gene ID 10075) and refer to the protein as Huwe1. All
of our two-hybrid isolates contain portions of the carboxy-
terminal catalytic domain of Huwe1 (Figure 3C). Interest-
ingly, this sequence is distinct from both the reported myc-
interaction region of Huwe1 just amino-terminal to the
HECT domain (Adhikary et al., 2005) and the BH3 motif at
amino acids 1972–1999, which binds Mcl-1 (Warr et al., 2005;
Zhong et al., 2005). We constructed derivatives of the Cdc6
two-hybrid fusion in which increasing amounts of the amino
terminal (noncatalytic) domain were deleted and tested
them for interaction with the Huwe1 fusions. Removal of as
many as the first 154 amino acids, but not the first 192, from
Cdc6 had no effect on the two-hybrid interaction of Cdc6
with Huwe1, demonstrating that this region is dispensable
for the Cdc6-Huwe1 interaction (Figure 3B). We note that
the catalytic domain of Cdc6 is the most highly conserved
domain and is included in the constructs that retain binding
to the most highly conserved domain of Huwe1.
We confirmed that Cdc6 and Huwe1 interact biochemi-
cally. For this purpose, we produced a fusion of GST to the
c-terminal domain of Huwe1 (amino acids 3987–4374 “GST-
Huwe1C”) in Escherichia coli. Glutathione beads coated with
GST or GST- Huwe1C were incubated with a lysate of HeLa
cells expressing epitope-tagged Cdc6 (myc5-Cdc6). Under
these conditions, Cdc6 bound to Huwe1, but not to GST
control beads (Figure 3D, compare lanes 2 and 3). Further-
more, GST-Cdc6 produced in insect cells coprecipitates en-
dogenous full-length Huwe1 from HeLa cell extracts (Figure
3E, compare lanes 2 and 3). To determine if these proteins
can bind in the absence of other cellular proteins (human or
yeast), we mixed purified recombinant Cdc6 with glutathi-
one beads coated with purified recombinant GST-Huwe1C.
Cdc6 was specifically retained on these beads, indicating
that these two proteins can interact directly (Figure 3F).
Finally, we tested if Huwe1 and Cdc6 associate when they
are expressed at their endogenous levels. To determine if
Huwe1 and Cdc6 interact during a DNA damage response,
we irradiated cells with UV (or left them untreated) and then
added MG132 to block the degradation of Cdc6. We pre-
pared nuclear lysates from HeLa cells and released Cdc6
from chromatin with nuclease. These extracts were subjected
to immunoprecipitation with anti-Huwe1 antibodies and
then probed for endogenous Cdc6. Cdc6 was found in
Huwe1 immunoprecipitates both in the absence and in the
presence of DNA damage (Figure 3G, lanes 5 and 6).
If Huwe1 is the ubiquitin ligase that controls Cdc6 degra-
dation, then Huwe1 should be able to ubiquitinate Cdc6. We
therefore tested the ability of full-length (492 kDa) recombi-
nant Huwe1 purified from insect cells (Zhong et al., 2005) to
polyubiquitinate recombinant Cdc6 in vitro. We incubated
purified GST-Cdc6 with Huwe1 in the presence of E1 and E2
enzymes and ubiquitin under conditions similar to those
initially defined for ubiquitination of the Mcl-1 protein by
Huwe1 (a.k.a. Mule; Zhong et al., 2005). Substantial poly-
ubiquitination of Cdc6 was detected by immunoblot analy-
sis of the reaction products, and the ubiquitination was
dependent on the concentration of Huwe1 (Figure 3H, com-
pare lanes 2–4). These results suggest that Huwe1 binds
Cdc6 for the purpose of catalyzing Cdc6 ubiquitination and
that Huwe1 may play a role in Cdc6 stability in cells.
Huwe1-dependent Regulation of Cdc6 Stability in Cells
Huwe1 is not induced by DNA damage (Figures 3G and 4,
A–E), suggesting that some mechanism other than enhanced
expression must operate to promote Cdc6 ubiquitination
after DNA damage. To explore how Cdc6 becomes unstable
after DNA damage, we tested if Cdc6 chromatin association
is affected by DNA damage. HeLa cells were UV irradiated
and harvested at different times after UV treatment up to 3 h.
Additional cells were simultaneously treated with UV irra-
diation and MG132 to block Cdc6 degradation. Nonionic
detergent insoluble pellets were prepared from these cells,
and DNA-bound proteins were released from these pellets
with micrococcal nuclease. Proteins released by nuclease
digestion were defined as the chromatin-bound proteins,
and their abundance was compared with their overall abun-
dance in portions of the starting whole cell lysates. In naive
HeLa cells, Cdc6 is readily detected in chromatin fractions
(Figure 4A, lanes 1 and 8). Within 30 min after UV treatment,
the amount of Cdc6 remaining on chromatin was substan-
tially reduced (Figure 4A, compare lanes 8 and 9), even
though at this early time point the overall amount of Cdc6 in
the whole cell lysate was still largely unchanged (Figure 4A,
compare lanes 1 and 2). Most strikingly, when Cdc6 degra-
dation was blocked with MG132, the overall level of Cdc6
protein remained unchanged, as expected (Figure 4A, com-
pare lanes 1 and 7), but the amount of chromatin bound
Cdc6 was almost undetectable (Figure 4A, compare lanes 8
and 14). Importantly, Huwe1 itself is not appreciably asso-
ciated with chromatin either before or after DNA damage
(Figure 4A, lanes 8–14). These data suggest that Cdc6 is
released from chromatin after DNA damage into the soluble
fraction where it can associate with the soluble Huwe1. This
mechanism of induced interaction was not detectable in the
coimmunoprecipitation experiments in Figure 3G because
Cdc6 required solubilization by nuclease digestion of the
lysates before immunoprecipitation.
To test if Huwe1 is required for the degradation of Cdc6 in
cells, we designed siRNA molecules to target the Huwe1
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mRNA. Cells transfected with Huwe1 siRNA showed sig-
nificant knockdown of endogenous Huwe1 protein after
48 h (Figure 4B, middle panel, compare lanes 1–3 with lanes
4–6). Asynchronous cells transfected with control siRNA
Figure 3. The ubiquitin E3 ligase, Huwe1, binds Cdc6 and catalyzes its polyubiquitination. (A) A schematic of the full-length Huwe1 protein (also
known as Mule, Lasu1, ARF-BP1, UreB1, and HectH9) is provided: DUF908 and DUF913, conserved domains of unknown function; UBA, ubiquitin
association domain; WWE motif, conserved putative protein interaction motif; BH3, Bcl-2 homology region 3; HECT, homologous to E6-AP carboxy
terminus (catalytic domain). (B) Gal4 DNA-binding domain fusions to the indicated Cdc6 sequences were expressed in a yeast reporter strain
(PJ69a) with the carboxy-terminal 240 residues of Huwe1 fused to the Gal4 transcriptional activation domain. Interaction was scored relative to
growth of the empty vector control on selective medium containing 30 mM 3-amino-1,2,4-triazole. (C) A schematic of independent isolates of
two-hybrid fusions to Huwe1 from Cdc6 interaction screens is shown. The amino acids included in each library clone are given; the longest clone
was isolated twice. (D) The catalytic domain of Huwe1 (Huwe1C) was produced as a GST fusion in E. coli and incubated with a lysate of HeLa cells
infected with adenovirus directing production of Cdc6 fused to five copies of the myc epitope tag (myc5-Cdc6). Ectopic Cdc6 in portions of the input
(5%) and in the fractions bound to glutathione beads was detected with anti-myc antibody. (E) GST and GST-Cdc6 were produced in insect cells
from a baculoviral vector, isolated on glutathione beads, and incubated with a HeLa cell lysate. Endogenous Huwe1 in portions of the input (5%)
and in the bound fractions was detected with anti-Huwe1 antibody. (F) Cdc6 purified as a GST fusion from insect cells and cleaved from GST with
thrombin was incubated with glutathione beads in the presence of purified GST-Huwe1C. Cdc6 in the bound (lanes 2–4) and input (10%, lane 1)
fractions was detected with anti-Cdc6 antibody; GST- Huwe1C was detected by Coomassie staining. (G) Nuclear extracts of HeLa cells treated with
MG132 for 3 h (lanes 1, 3, and 5) or with MG132 for 3 h after 30 J of UV irradiation (lanes 2, 4, and 6) were digested with micrococcal nuclease to
release Cdc6 from chromatin and then subjected to immunoprecipitation with normal rabbit serum (lanes 3 and 4) or anti-Huwe1 antibody (lanes
5 and 6). Endogenous Cdc6 and Huwe1 in the input (1%, lanes 1 and 2) and bound fractions (lanes 3–6) were detected by immunoblotting. (H)
Purified GST-Cdc6 (100 ng) was incubated with ubiquitin, E1, and E2 enzymes plus the indicated concentrations of purified Huwe1 for 2 h as
described in Materials and Methods. The reaction products were resolved by 6% SDS-PAGE and immunoblotted with anti-Cdc6 antibody.
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rapidly degraded Cdc6 after DNA damage induced by UV,
but cells with reduced Huwe1 did so considerably less effi-
ciently (Figure 4B, top panel, compare lanes 1–3 with lanes
4–6). This result is similar to the effects of DDB1 knockdown
on Cdt1 stability after DNA damage (Figure 2E) in that
Huwe1-depleted cells are hypomorphic for Cdc6 degrada-
tion.
If reduction of Huwe1 induced a delay or arrest in G2,
then Cdc6 levels might simply have been higher as a conse-
quence of an indirect cell cycle effect. However, duplicate
cultures treated with Huwe1 siRNA and analyzed by flow
cytometry showed no differences in cell cycle distributions
(Figure 4C). When we cultured cells lacking Huwe1 for an
additional 3 days, we noted a significant proliferation defect,
in keeping with reports by others (Adhikary et al., 2005;
Figure 4C), but we observed no apparent changes in cell
cycle distribution compared with control cultures even at 5
days after transfection (data not shown). The growth arrest
is not associated with robust changes in Cdc6 (data not
shown), but may be explained by deregulation of other
Figure 4. Huwe1 is required for Cdc6 degradation
after DNA damage. (A) Asynchronous HeLa cells
were irradiated with UV and harvested at the indi-
cated time points. The sample harvested 3 h after UV
treatment was duplicated and treated with MG132
immediately after irradiation. Cells were fraction-
ated into whole cell lysates and chromatin bound
fractions and probed for endogenous Cdc6, Huwe1,
and Orc2. (B) Asynchronous HeLa cells were trans-
fected with Huwe1 siRNA (lanes 4–6) or control
siRNA (lanes 1–3) for 48 h. Cells were irradiated
with UV as in Figure 1A, and endogenous Cdc6,
Huwe1, and tubulin were detected by immunoblot-
ting. (C) Left, HeLa cells treated with control siRNA
or Huwe1 siRNA were fixed and stained with pro-
pidium iodide for analysis by flow cytometry 41 h
after transfection. Right, cell numbers after transfec-
tion with control siRNA or Huwe1 siRNA were
measured in duplicate cultures counted on 5 consec-
utive days. (D) HeLa cells were transfected with
control siRNA (lanes 1–3) or Huwe1 siRNA (lanes
4–6) for 18 h followed by addition of thymidine for
18 h, for a total of 36 h in siRNA. Cells were treated
with 1 mM MMS or 30 J/m2 UV 3 h before harvest
in the continued presence of thymidine. Relative
Cdc6 abundance was determined by densitometry
and normalized to tubulin with the amount of Cdc6
in the first lane arbitrarily set to 1. (E) Left, HeLa
cells were transfected with control siRNA or Huwe1
siRNA and blocked in S phase with thymidine as in
Figure 4D. Cells were subjected to UV irradiation,
and cycloheximide was immediately added to10
g/ml in the continued presence of thymidine. Sam-
ples were collected at 0, 1, 2, and 4 h after UV
treatment. Right, semilog plot of the initial rate of
Cdc6 decay. The average half-life of Cdc6 in control-
treated cells is 1.2 (0.18) h, and in Huwe1 siRNA-
treated cells is 4.7 (0.8) h.
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Huwe1 substrates such as c-myc and Mcl-1 (Adhikary et al.,
2005; Chen et al., 2005; Warr et al., 2005; Zhong et al., 2005).
We thus conclude that the increased Cdc6 in UV-treated
cells as a consequence of the loss of Huwe1 is not a reflection
of a cell cycle arrest, but rather a more direct effect on
steady-state Cdc6 abundance.
Two-thirds of the asynchronous Huwe1-depleted cells in
Figure 4B were in G1 (Figure 4C). Presumably these cells
contained active APC, which may have contributed to Cdc6
ubiquitination in the absence of Huwe1. To focus specifically
on the APC-independent degradation of Cdc6, we arrested
cells in S phase by treatment with thymidine. In thymidine-
arrested cells in the absence of DNA damage, Cdc6 is stable
because APC in inactive. This assertion is supported by the
observation that treatment of S phase cells with the protea-
some inhibitor MG132 had no effect on Cdc6 abundance
(Petersen et al., 2000 and Figure S3A). In response to DNA
damage, however, S phase cells degraded Cdc6 after UV or
MMS treatment (Figure 4D, compares lanes 2 and 3 to lane
1). In marked contrast, we observed much less degradation
of Cdc6 after DNA damage caused by either UV or MMS in
Huwe1-depleted cells (Figure 4D, compare lanes 5 and 6 to
lane 4). Reduction of Huwe1 with a different siRNA mole-
cule had the same effect (Supplementary Figure S3B).
It was possible that Huwe1 regulated Cdc6 abundance by
indirectly controlling Cdc6 transcription or translation. We
occasionally (though not consistently) observed an increase
in Cdc6 abundance after Huwe1 depletion even in the ab-
sence of exogenous damage (for instance, Figure 4D, com-
pare lanes 1 and 4). The fact that Cdc6 is not normally
ubiquitinated in S phase–arrested cells suggests that Huwe1
depletion may have affected Cdc6 levels before the arrest so
that they arrived in S phase with more Cdc6. It is also
possible that endogenous sources of DNA damage may
restrict Cdc6 abundance through Huwe1. Alternatively
Huwe1 may regulate Cdc6 synthesis indirectly through
transcriptional mechanisms involving other Huwe1 sub-
strates such as c-myc or p53. To distinguish effects of
Huwe1-depletion on Cdc6 stability from effects on Cdc6
synthesis, we treated control cells or Huwe1-depleted cells
with cycloheximide (CHX) to block new protein synthesis.
We monitored the loss of Cdc6 after treatment of thymidine-
blocked HeLa cells with both UV irradiation and CHX. In
CHX-treated cells, Cdc6 was degraded after UV irradiation
(Figure 4E, lanes 1–4), demonstrating that upregulation of
UV-induced genes is not required for Cdc6 degradation
after DNA damage. Depletion of Huwe1 had no effect on the
degradation of Cdt1 (Supplementary Figure S4A) or on the
accumulation of p53 (Supplementary Figure S4B), indicating
that Huwe1 depletion does not interfere with the DNA
damage response. Importantly, Cdc6 persisted in UV-irradi-
ated Huwe1-deficient cells even in the presence of CHX
(Figure 4E, compare lanes 2–4 with lanes 6–8). This result
demonstrates that Huwe1 is required for Cdc6 degradation
per se and that any potential indirect effects of Huwe1 that
might have occurred through transcriptional regulation of
cdc6 or other genes cannot account for the persistence of
Cdc6 after DNA damage. The defect in Cdc6 degradation
was most dramatic in the first hours after irradiation; the
remaining Huwe1 was presumably capable of supporting
some Cdc6 degradation over the full course of 4 h, though
even at this late time point, more Cdc6 persists in Huwe1-
deficient cells than in control cells (Figure 4E). During the
initial 2 h after UV treatment the half-life of Cdc6 increased
from 1.2 h in control cells to 4.7 h in cells with reduced
Huwe1 (Figure 4E, compare lanes 4 and 8). Therefore,
Huwe1 is required for Cdc6 degradation after DNA damage
at times when APC is inactive.
Conservation of Huwe1-dependent Regulation of Cdc6
Huwe1 is an evolutionarily conserved ubiquitin ligase; sim-
ilar sequences containing not only a C-terminal catalytic
domain, but also the two N-terminal conserved domains of
unknown function (DUF908 and DUF913, Figure 3A) not
present in other HECT family ligases are identifiable in the
genomes of plants, flies, worms, and yeast. In the budding
yeast Saccharomyces cerevisiae, the Huwe1 ortholog is Tom1
for temperature-dependent organization in mitotic nucleus
(distinct from the human Tom1 protein, target of Myb1).
Yeast Tom1, like Huwe1, has been proposed to have multi-
ple nuclear substrates, and tom1 mutants are temperature-
sensitive for growth at 37°C (Saleh et al., 1998; Utsugi et al.,
1999). To test if the Huwe1-dependent degradation of Cdc6
is similarly conserved in budding yeast, we constructed
isogenic wild-type and tom1 deletion strains in which the
endogenous cdc6 gene has been modified to include 13 tan-
dem copies of the myc epitope. Cultures of these strains
were grown at 30°C (the permissive temperature), and then
treated with MMS. Wild-type yeast cells degraded Cdc6-
myc within 60 min, but showed no loss of endogenous yeast
Mcm2 or PGK (Figure 5A, lanes 1–3). Deletion of the Huwe1
ortholog, tom1, resulted in somewhat increased Cdc6 in
Figure 5. Conservation of Huwe1 regulation of Cdc6. (A) Yeast
strains JCY200 WT and JCY201 tom1 in which the endogenous
Cdc6 locus bears an in-frame insertion of 13 myc epitopes at the 3
end of the Cdc6 open reading frame were grown in YPD and treated
with 0.05% (vol/vol) MMS. Time points were collected following
the addition of MMS, and Cdc6 was detected by immunoblotting
with the anti-myc antibody; endogenous Mcm2 and phosphoglyc-
erate kinase immunoblots are shown as controls. (B) Model: Cdc6
degradation by APC and Huwe1 after DNA damage contributes to
the balance between cell growth and apoptosis. Under normal cell
growth conditions, Huwe1 activates c-myc and induces p53 degra-
dation. Cdc6 stability is primarily controlled by APC as cells transit
mitosis. In response to DNA damage, p53 is stabilized, but Mcl-1
and Cdc6 are ubiquitinated and degraded. See text for discussion.
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naive cells, but importantly, significantly less Cdc6-myc
degradation in the presence of MMS (Figure 5A, lanes 4–6).
At the nonpermissive temperature (37°C), tom1 mutants
display a G2/M arrest accompanied by defects in protein
synthesis (Utsugi et al., 1999). To rule out effects on Cdc6
abundance due to potential cell cycle changes that might
have manifested even at the permissive temperature, we
monitored the budding of both wild-type and tom1 strains
grown at 30°C. We found no differences in the relative
numbers of unbudded, small-budded, or large-budded cells,
and we observed only minor differences in the overall
growth rate at 30°C (data not shown). Given these observa-
tions, plus the fact that yeast Cdc6 is most abundant in G1
rather than G2 (Piatti et al., 1995; Drury et al., 1997), it seems
unlikely that the enhanced levels of Cdc6 were due to roles
of Tom1 in G2/M progression or protein synthesis. These
results indicate that Tom1 is required for degradation of
yeast Cdc6 after DNA damage and suggest that the regula-
tion of Cdc6 abundance by Huwe1-type ubiquitin ligases is
conserved.
DISCUSSION
Taken together, the results presented here indicate that Cdc6
ubiquitination induced by both UV irradiation and by DNA
alkylation can be carried out by the Huwe1 enzyme. This
study complements previous work on the cell cycle– and
ionizing radiation–induced ubiquitination of Cdc6 carried
out by APCCdh1(Petersen et al., 2000; Duursma and Agami,
2005; Mailand and Diffley, 2005) The demonstration of two
independent ubiquitin ligases for Cdc6 is another example
of a common theme in cell cycle regulation, namely multiple
overlapping regulatory mechanisms. Presumably these mul-
tiple pathways evolved to ensure tight control over essential
processes under a variety of conditions.
DNA damage sufficient to induce Cdk2 inhibition can
accelerate Cdc6 degradation by inhibiting the protective
phosphorylation at Ser54, but this mechanism can only op-
erate when APC is active (Duursma and Agami, 2005). On
the other hand, we find that Huwe1 ubiquitination of Cdc6
can occur in S phase, even when Cdc6 has been altered to
mimic phosphorylation by Cdk2. Therefore, like Cdt1,
which associates with two different ubiquitin ligase com-
plexes, Skp2 and Cul4, (Li et al., 2003; Kondo et al., 2004; Liu
et al., 2004; Sugimoto et al., 2004; Takeda et al., 2005; Hu and
Xiong, 2006; Senga et al., 2006), Cdc6 is regulated by both
APC and Huwe1. Because the human genome contains
many thousands of potential origins, these different control
pathways may be required to prevent relicensing at even a
small percentage of origins. Multiple mechanisms may also
need to be in place to adequately respond to a variety of
cellular insults.
DNA damage activates an intracellular signaling pathway
that culminates in cell cycle checkpoint arrest through inhi-
bition of Cdks (reviewed in Abraham, 2001; Sancar et al.,
2004). If the damage occurs during S phase or G2 and is
subsequently repaired (instead of inducing apoptosis), then
cells could recover with new preRCs on the already dupli-
cated DNA. Even though geminin is not degraded after
DNA damage (Higa et al., 2003 and our unpublished obser-
vations), the persistence of geminin during a checkpoint
response is not sufficient to block substantial preRC reas-
sembly. This assertion is supported by previous findings
that direct inhibition of Cdk activity during G2, either phar-
macologically or genetically, permits reloading of MCM pro-
teins onto chromatin even in the presence of geminin (Bates
et al., 1998; Ballabeni et al., 2004; Zhu et al., 2005). Thus, there
is a risk of genome instability if preRCs are permitted to
assemble while Cdk activity is inhibited. Presumably to
guard against this threat, both Cdc6 and Cdt1 are actively
degraded after DNA damage, and we suggest that the deg-
radation during S phase and G2 is particularly important.
The Huwe1-dependent mechanism of Cdc6 degradation
after DNA damage caused by UV radiation or MMS is
distinct from the APCCdh1-dependent mechanism of Cdc6
degradation caused by ionizing radiation (IR). Substantial
IR-induced Cdc6 degradation is only observed in p53-pro-
ficient cells and requires induction of p21 expression
(Duursma and Agami, 2005). In contrast, Cdc6 degradation
induced by UV radiation, MMS, or adozelesin (another
DNA alkylating compound) occurs equally well in both
p53-proficient and p53-deficient cells (Figure 2C and Blan-
chard et al., 2002). The cellular response to IR is primarily
mediated by the ATM and Chk2 kinases that are stimulated
by double-strand DNA breaks. On the other hand, most
other forms of DNA damage, including UV and MMS-in-
duced damage, primarily trigger activation of the ATR and
Chk1 kinases. These two kinase cascades are related but
distinct in both the signals that trigger their activation and in
their primary substrates. It is possible that differences in the
kinase pathways that are activated by DNA damage account
for the different mechanisms of Cdc6 degradation. In sup-
port of a contribution of ATR/ATM checkpoint kinases to
Cdc6 degradation, we observe partial stabilization of Cdc6
after DNA damage in the presence of caffeine (Supplemen-
tary Figure S5).
Cdc6 is substantially overproduced in a wide variety of
cancer cell types. This overproduction results in a longer
time needed to eliminate Cdc6 protein from cancer cells
experiencing DNA damage than from normal cells, leaving
a longer window of opportunity for these cells to assemble
preRCs. The abundant Cdc6 that arises from near ubiquitous
deregulation of the E2F-RB transcriptional program in can-
cers could contribute to the observed genomic instability
associated with transformation. We note that most cancer
cells also have a disrupted p53 pathway that could blunt the
APC-mediated mechanism of Cdc6 degradation. Thus
Huwe1, which is also highly expressed in multiple tumor
cell lines (Chen et al., 2005; Yoon et al., 2005), may represent
the primary means of degrading Cdc6 in p53-null cells and
may be particularly important in the response to chemother-
apies that damage DNA.
Huwe1-depletion in the absence of DNA damage did not
result in overt rereplication (data not shown). If the purpose
of Cdc6 degradation after DNA damage is to prevent re-
replication, then it is likely that in order to observe signifi-
cant rereplication in these short-term assays, not only would
Cdc6 degradation need to be blocked, and perhaps Cdt1
degradation, but Cdk activity would need to be maintained
in order to permit origin firing. We suggest however that
over the course of many cell cycles the degradation of both
Cdc6 and Cdt1 when cells encounter DNA damage contrib-
utes to maintaining strict regulation of preRC assembly or to
promoting appropriate checkpoint and apoptotic responses.
Consistent with this model, modest overproduction of Cdt1
has minimal effects on the growth properties or genome
stability in cultured mouse cells, but those cells have a
higher propensity for tumorigenesis in vivo (Arentson et al.,
2002). We predict that stabilization of Cdc6 would have a
similar phenotype, particularly in sensitized backgrounds or
in cells subjected to repeated rounds of sublethal DNA
damage.
Although most of the other known targets of Huwe1 (p53,
Mcl-1, and c-myc) are specific to metazoan species, Huwe1-
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dependent regulation of Cdc6 may be ubiquitous in eu-
karyotes, because both human and yeast cells rely on this
conserved enzyme for Cdc6 degradation. Cdc6 is certainly
not the only target of Huwe1; Huwe1 is a very large protein
with multiple protein–protein interaction domains for bind-
ing other proteins (Adhikary et al., 2005; Chen et al., 2005;
Warr et al., 2005; Zhong et al., 2005). We propose the follow-
ing model to accommodate what is currently understood
concerning the regulation of human Cdc6 after DNA dam-
age in the context of other recently identified Huwe1 sub-
strates (illustrated in Figure 5B): During normal cell growth,
Huwe1 ubiquitinates p53 to induce p53 degradation (Chen
et al., 2005) and ubiquitinates and activates c-myc (Adhikary
et al., 2005). Huwe1 ubiquitinates the anti-apoptotic Mcl-1
protein but its access to Mcl-1 is not obvious until cells are
exposed to DNA damage (Zhong et al., 2005, and Zhong,
unpublished observations). Hence, under normal growth
conditions cells have active c-myc transcription, low p53,
high Mcl-1, and cell cycle–regulated Cdc6 levels that are
controlled by a combination of E2F-dependent transcription
and APC-mediated degradation, and this combination sup-
ports robust proliferation (Figure 5B, left). In response to
DNA damage Huwe1 ubiquitinates Cdc6 and Mcl-1 to in-
duce their degradation, but no longer ubiquitinates p53,
resulting in low Cdc6 and Mcl-1 with stabilized p53, thus
promoting cell cycle arrest, apoptosis, and inhibition of new
preRC assembly (Figure 5B, right).
Given the role of Huwe1 in the regulation of Cdc6, p53,
c-myc, and Mcl-1, one might speculate that Huwe1 activity
is regulated by DNA damage signals. Nevertheless we do
not detect changes in Huwe1 protein levels after DNA dam-
age (Figures 3G and 4, A, B, D, and E) or during cell cycle
progression (Supplementary Figure S2). Instead, we find
that Cdc6 is lost from the chromatin fraction after DNA
damage and may have greater access to the soluble Huwe1
under these conditions. The mechanism by which Cdc6 is
released from chromatin is not yet known, but clearly does
not involve degradation of Orc2 (Figure 4A). It is tempting
to speculate that one or more of the DNA damage signaling
kinases regulates the chromatin association of Cdc6. This
study prompts significant questions regarding the intracel-
lular context of the Huwe1-Cdc6 interaction and the up-
stream regulators of Huwe1 and/or Cdc6 during a DNA
damage response. The regulation of Cdc6 by Huwe1 is likely
to be complex, and its elucidation is an important future
goal.
Note added in proof. While this manuscript was in review,
Matsuoka et al. (2007) isolated Huwe1 in a screen for pro-
teins phosphorylated by the ATR and ATM kinases in re-
sponse to DNA damage.
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